FAITH - Factor XA Inhibitor-Related InTracranial Haemorrhage

CompletedOBSERVATIONAL
Enrollment

123

Participants

Timeline

Start Date

July 8, 2024

Primary Completion Date

November 1, 2024

Study Completion Date

November 1, 2024

Conditions
InTracranial Haemorrhage
Trial Locations (10)

Unknown

Research Site, Buenos Aires

Research Site, Joinville

Research Site, Porto Alegre

Research Site, Bogotá

Research Site, Mexico City

Research Site, Doha

Research Site, Mecca

Research Site, Riyadh

Research Site, Abu Dhabi

Research Site, Al Ain City

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY